Anti‐cancer stem cell activity of a hedgehog inhibitor <scp>GANT</scp>61 in estrogen receptor‐positive breast cancer cellsJunichi Kurebayashi, Takuya Moriya|Cancer Science|2017Cited by 44
Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtypeJunichi Kurebayashi, Hiroshi Sonoo|BMC Cancer|2010Cited by 43
Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cellsRyohei Ogata, Junichi Kurebayashi|Breast Cancer|2020Cited by 38